GGrantIndex
Sort

82,697 grants matching vaccine development

DEVELOPMENT OF UM-1098: A NOVEL SYNTHETIC TH17 INDUCING ADJUVANT AND DELIVERY SYSTEM

$2,419,904
Jay Evans · University Of Montana · N01 · FY2023 · AI

Influenza Viral Pathogenesis

$2,419,893
Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network

$2,419,351
Elizabeth Renata Brown · Fred Hutchinson Cancer Research Center · UM1 · FY2013 · AI

Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases

$2,418,769
Hong-Wei Sun · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2023 · AR

Establishment of a SPF Rhesus Macaque Colony

$2,417,980
Deepak Kaushal · Texas Biomedical Research Institute · U42 · FY2024 · OD

Establishment of a SPF Rhesus Macaque Colony

$2,417,980
Deepak Kaushal · Texas Biomedical Research Institute · U42 · FY2023 · OD

Establishment of a SPF Rhesus Macaque Colony

$2,417,980
Deepak Kaushal · Texas Biomedical Research Institute · U42 · FY2025 · OD

Prevention of AIDS

$2,417,438
Barbara Felber · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

General Clinical Research Center

$2,417,131
E Albert Reece · University Of Maryland Baltimore · M01 · FY2007 · RR

Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease

$2,416,808
Lisa Rider · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES

UNC Center for AIDS Research

$2,415,841
Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2009 · AI

Nonhuman Primate (NHP) Core Functional Genomics Laboratory for AIDS Vaccine Research and Development

$2,415,424
Michael Gale · University Of Washington · N01 · FY2020 · AI

Role of inflammation, innate resistance, and immunity in carcinogenesis.

$2,415,233
Giorgio Trinchieri · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling

$2,414,999
Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2016 · HG

A NOVEL VEE REPLICON VACCINE FOR HIV

$2,414,394
University Of North Carolina Chapel Hill · P01 · FY2002 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$2,413,871
Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2018 · AI

Influenza and Emerging Infectious Diseases

$2,412,678
Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

The Johns Hopkins University-Blantyre Clinical Trials Unit

$2,412,151
Taha E Taha · Johns Hopkins University · UM1 · FY2023 · AI

SPORE in Cervical Cancer

$2,412,090
T.-C. Wu · Johns Hopkins University · P50 · FY2007 · CA

Mayo Clinic Breast Cancer SPORE

$2,411,640
Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2025 · CA

Adoptive Cell Transfer Immunotherapy of Cancer

$2,411,384
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Rustbelt Center for AIDS Research (Case/UHC-Pitt CFAR)

$2,411,000
Jonathan Karn · Case Western Reserve University · P30 · FY2023 · AI

Rustbelt Center for AIDS Research (Case/UHC-Pitt CFAR)

$2,411,000
Jonathan Karn · Case Western Reserve University · P30 · FY2022 · AI

CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES

$2,410,479
Barbara Driver · Westat, Inc. · N01 · FY2021 · HD

Virologic and Immunologic Sample Acquisition Core

$2,410,342
David W Kimberlin · Vanderbilt University Medical Center · U19 · FY2024 · AI